These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27418149)

  • 1. Bacteroides fragilis metabolises exopolysaccharides produced by bifidobacteria.
    Rios-Covian D; Cuesta I; Alvarez-Buylla JR; Ruas-Madiedo P; Gueimonde M; de Los Reyes-Gavilán CG
    BMC Microbiol; 2016 Jul; 16(1):150. PubMed ID: 27418149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
    Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
    Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Bifidobacterium and Bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria.
    Rios-Covian D; Arboleya S; Hernandez-Barranco AM; Alvarez-Buylla JR; Ruas-Madiedo P; Gueimonde M; de los Reyes-Gavilan CG
    Appl Environ Microbiol; 2013 Dec; 79(23):7518-24. PubMed ID: 24077708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria.
    Salazar N; Gueimonde M; Hernández-Barranco AM; Ruas-Madiedo P; de los Reyes-Gavilán CG
    Appl Environ Microbiol; 2008 Aug; 74(15):4737-45. PubMed ID: 18539803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.
    Salazar N; Binetti A; Gueimonde M; Alonso A; Garrido P; González del Rey C; González C; Ruas-Madiedo P; de los Reyes-Gavilán CG
    Int J Food Microbiol; 2011 Jan; 144(3):342-51. PubMed ID: 21078530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of exopolysaccharides by Lactobacillus and Bifidobacterium strains of human origin, and metabolic activity of the producing bacteria in milk.
    Salazar N; Prieto A; Leal JA; Mayo B; Bada-Gancedo JC; de los Reyes-Gavilán CG; Ruas-Madiedo P
    J Dairy Sci; 2009 Sep; 92(9):4158-68. PubMed ID: 19700676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria.
    Rios-Covian D; Sánchez B; Salazar N; Martínez N; Redruello B; Gueimonde M; de Los Reyes-Gavilán CG
    Front Microbiol; 2015; 6():825. PubMed ID: 26347720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of exopolysaccharides produced by Bifidobacterium longum NB667 and its cholate-resistant derivative strain IPLA B667dCo.
    Salazar N; Ruas-Madiedo P; Prieto A; Calle LP; de Los Reyes-Gavilán CG
    J Agric Food Chem; 2012 Feb; 60(4):1028-35. PubMed ID: 22229884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Aloe vera whole leaf extract on short chain fatty acids production by Bacteroides fragilis, Bifidobacterium infantis and Eubacterium limosum.
    Pogribna M; Freeman JP; Paine D; Boudreau MD
    Lett Appl Microbiol; 2008 May; 46(5):575-80. PubMed ID: 18363656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin Cross-Feeding of Infant Bifidobacteria and Eubacterium hallii.
    Bunesova V; Lacroix C; Schwab C
    Microb Ecol; 2018 Jan; 75(1):228-238. PubMed ID: 28721502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro kinetic analysis of oligofructose consumption by Bacteroides and Bifidobacterium spp. indicates different degradation mechanisms.
    Van der Meulen R; Makras L; Verbrugghe K; Adriany T; De Vuyst L
    Appl Environ Microbiol; 2006 Feb; 72(2):1006-12. PubMed ID: 16461642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a growth medium suitable for exopolysaccharide production and structural characterisation by Bifidobacterium animalis ssp. lactis AD011.
    Alhudhud M; Humphreys P; Laws A
    J Microbiol Methods; 2014 May; 100():93-8. PubMed ID: 24632517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beneficial effect of exopolysaccharides from Bifidobacterium bifidum WBIN03 on microbial diversity in mouse intestine.
    Li S; Chen T; Xu F; Dong S; Xu H; Xiong Y; Wei H
    J Sci Food Agric; 2014 Jan; 94(2):256-64. PubMed ID: 23716082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bifidobacteria-produced exopolysaccharides on human gut microbiota in vitro.
    Liu G; Chen H; Chen J; Wang X; Gu Q; Yin Y
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1693-1702. PubMed ID: 30569218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exopolysaccharides Produced by Lactic Acid Bacteria and Bifidobacteria as Fermentable Substrates by the Intestinal Microbiota.
    Salazar N; Gueimonde M; de Los Reyes-Gavilán CG; Ruas-Madiedo P
    Crit Rev Food Sci Nutr; 2016 Jul; 56(9):1440-53. PubMed ID: 25675369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exopolysaccharides produced by Lactobacillus and Bifidobacterium strains abrogate in vitro the cytotoxic effect of bacterial toxins on eukaryotic cells.
    Ruas-Madiedo P; Medrano M; Salazar N; De Los Reyes-Gavilán CG; Pérez PF; Abraham AG
    J Appl Microbiol; 2010 Dec; 109(6):2079-86. PubMed ID: 20846331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteomic approach towards understanding the cross talk between Bacteroides fragilis and Bifidobacterium longum in coculture.
    Rios-Covián D; Sánchez B; Martínez N; Cuesta I; Hernández-Barranco AM; de Los Reyes-Gavilán CG; Gueimonde M
    Can J Microbiol; 2016 Jul; 62(7):623-8. PubMed ID: 27156738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emulsifying, rheological and physicochemical properties of exopolysaccharide produced by Bifidobacterium longum subsp. infantis CCUG 52486 and Bifidobacterium infantis NCIMB 702205.
    Prasanna PH; Bell A; Grandison AS; Charalampopoulos D
    Carbohydr Polym; 2012 Sep; 90(1):533-40. PubMed ID: 24751074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Bifidobacterium sp. growth stimulation of exopolysaccharide produced by Enterococcus faecalis EJRM152 isolated from human breast milk.
    Kansandee W; Moonmangmee D; Moonmangmee S; Itsaranuwat P
    Carbohydr Polym; 2019 Feb; 206():102-109. PubMed ID: 30553302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus.
    Ruas-Madiedo P; Gueimonde M; Margolles A; de los Reyes-Gavilán CG; Salminen S
    J Food Prot; 2006 Aug; 69(8):2011-5. PubMed ID: 16924934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.